Loading…
Reported covered position: Health Policy Director of the U.S. Senate Committee on Health, Education, Labor and Pensions
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PROVIDER RESOURCES LLC via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Issues regarding the No Surprises Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Source: Senate LDA
| THERMO FISHER SCIENTIFIC |
| 8 |
| 2024–2025 |
| COLLEGE OF AMERICAN PATHOLOGISTS | 7 | 2024–2025 |
| GUARDANT HEALTH | 7 | 2024–2025 |
| SENSEONICS, INC. | 7 | 2024–2025 |
| DATASPRING (FKA COUNCIL FOR AFFORDABLE QUALITY HEALTHCARE) | 4 | 2026 |
| PROVIDER RESOURCES LLC | 2 | 2026 |
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DATASPRING via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Provider directory and provider credentialing issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PROVIDER RESOURCES LLC via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · RR
Issues regarding the No Surprises Act
DATASPRING via MANATT, PHELPS, AND PHILLIPS
2026 · second_quarter · Q2
Provider directory and provider credentialing issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2026 · second_quarter · Q2
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DATASPRING via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Provider directory and provider credentialing issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DATASPRING via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · RR
National Provider Directory and provider credentialing issues
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2025 · fourth_quarter · Q4
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Medicare payment issue for physicians and hospital outpatient departments, Centers for Medicare & Medicaid Services.
KAISER PERMANENTE via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Regulation of in vitro diagnostics and lab-developed tests
ROCHE DIAGNOSTICS via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Regulation of in vitro diagnostics and lab-developed tests
THERMO FISHER SCIENTIFIC via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Regulation of in vitro diagnostics and lab-developed tests
MAYO CLINIC via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Regulation of in vitro diagnostics and lab-developed tests
COLLEGE OF AMERICAN PATHOLOGISTS via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Regulation of in vitro diagnostics and lab-developed tests
ALEXION PHARMACEUTICALS via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Regulation of in vitro diagnostics and lab-developed tests
NEW YORK STEM CELL FOUNDATION via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Appropriations and Healthcare
Appropriations and Healthcare
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Medicare payment issue for physicians and hospital outpatient departments
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · 2T
Appropriations and Healthcare
Appropriations and Healthcare
KAISER PERMANENTE via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Regulation of in vitro diagnostics and lab-developed tests
ROCHE DIAGNOSTICS via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Regulation of in vitro diagnostics and lab-developed tests
THERMO FISHER SCIENTIFIC via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Regulation of in vitro diagnostics and lab-developed tests
MAYO CLINIC via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Regulation of in vitro diagnostics and lab-developed tests
COLLEGE OF AMERICAN PATHOLOGISTS via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Regulation of in vitro diagnostics and lab-developed tests
ALEXION PHARMACEUTICALS via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Regulation of in vitro diagnostics and lab-developed tests
NEW YORK STEM CELL FOUNDATION via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Appropriations and Healthcare
Appropriations and Healthcare
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
KAISER PERMANENTE via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Regulation of in vitro diagnostics and lab-developed tests
ROCHE DIAGNOSTICS via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Regulation of in vitro diagnostics and lab-developed tests
THERMO FISHER SCIENTIFIC via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Regulation of in vitro diagnostics and lab-developed tests
MAYO CLINIC via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Regulation of in vitro diagnostics and lab-developed tests
COLLEGE OF AMERICAN PATHOLOGISTS via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Regulation of in vitro diagnostics and lab-developed tests
ALEXION PHARMACEUTICALS via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Regulation of in vitro diagnostics and lab-developed tests
NEW YORK STEM CELL FOUNDATION via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Appropriations and Healthcare
Appropriations and Healthcare
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Appropriations and Healthcare
Appropriations and Healthcare
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Medicare payment issue for physicians and hospital outpatient departments
ALEXION PHARMACEUTICALS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
MAYO CLINIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
COLLEGE OF AMERICAN PATHOLOGISTS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
THERMO FISHER SCIENTIFIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
ROCHE DIAGNOSTICS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
KAISER PERMANENTE via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
ALEXION PHARMACEUTICALS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RA
Regulation of in vitro diagnostics and lab-developed tests
MAYO CLINIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RA
Regulation of in vitro diagnostics and lab-developed tests
THERMO FISHER SCIENTIFIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RA
Regulation of in vitro diagnostics and lab-developed tests
ROCHE DIAGNOSTICS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RA
Regulation of in vitro diagnostics and lab-developed tests
KAISER PERMANENTE via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RA
Regulation of in vitro diagnostics and lab-developed tests
THERMO FISHER SCIENTIFIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
MAYO CLINIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
ROCHE DIAGNOSTICS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
COLLEGE OF AMERICAN PATHOLOGISTS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
ALEXION PHARMACEUTICALS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
KAISER PERMANENTE via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · 4A
Regulation of in vitro diagnostics and lab-developed tests
MAYO CLINIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Regulation of in vitro diagnostics and lab-developed tests
MAYO CLINIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RA
Regulation of in vitro diagnostics and lab-developed tests
KAISER PERMANENTE via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Regulation of in vitro diagnostics and lab-developed tests
ROCHE DIAGNOSTICS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Regulation of in vitro diagnostics and lab-developed tests
THERMO FISHER SCIENTIFIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Regulation of in vitro diagnostics and lab-developed tests
COLLEGE OF AMERICAN PATHOLOGISTS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Regulation of in vitro diagnostics and lab-developed tests
ALEXION PHARMACEUTICALS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Regulation of in vitro diagnostics and lab-developed tests
KAISER PERMANENTE via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RR
Regulation of in vitro diagnostics and lab-developed tests
ROCHE DIAGNOSTICS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RR
Regulation of in vitro diagnostics and lab-developed tests
THERMO FISHER SCIENTIFIC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RR
Regulation of in vitro diagnostics and lab-developed tests
COLLEGE OF AMERICAN PATHOLOGISTS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RR
Regulation of in vitro diagnostics and lab-developed tests
ALEXION PHARMACEUTICALS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · RR
Regulation of in vitro diagnostics and lab-developed tests.
NEW YORK STEM CELL FOUNDATION via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Appropriations and Healthcare.
Appropriations and Healthcare.
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Appropriations and Healthcare.
Appropriations and Healthcare.
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Issues related to medical device reimbursement.
Issues related to medical device reimbursement.
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Medicare payment issue for physicians and hospital outpatient departments.
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · 3A
Medicare payment issue for physicians and hospital outpatient departments.
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · 3A
Issues related to medical device reimbursement.
Issues related to medical device reimbursement.
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Medicare payment issue for physicians and hospital outpatient departments.
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · RA
Medicare payment issue for physicians and hospital outpatient departments.
NEW YORK STEM CELL FOUNDATION via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Appropriations and Healthcare.
Appropriations and Healthcare.
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Appropriations and Healthcare.
Appropriations and Healthcare.
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Issues related to medical device reimbursement.
Issues related to medical device reimbursement.
NEW YORK STEM CELL FOUNDATION via MANATT, PHELPS, AND PHILLIPS
2024 · second_quarter · Q2
Appropriations and Healthcare
Appropriations and Healthcare
NEW YORK STEM CELL FOUNDATION via MANATT, PHELPS, AND PHILLIPS
2024 · first_quarter · Q1
Appropriations and Healthcare
Appropriations and Healthcare
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2024 · second_quarter · Q2
Appropriations and Healthcare
Appropriations and Healthcare
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2024 · first_quarter · Q1
Appropriations and Healthcare
Appropriations and Healthcare
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2024 · second_quarter · Q2
Issues related to medical device reimbursement
Issues related to medical device reimbursement.
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2024 · first_quarter · 1A
Issues related to medical device reimbursement.
Issues related to medical device reimbursement
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2024 · first_quarter · Q1
Issues related to medical device reimbursement
Issues related to medical device reimbursement
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2024 · second_quarter · RA
Issues related to medical device reimbursement.
Issues related to medical device reimbursement.
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2024 · second_quarter · RR
Medicare proposed inpatient prospective payment system rule.
Medicare proposed inpatient prospective payment system rule.
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2024 · second_quarter · RR
Appropriations and Healthcare
Appropriations and Healthcare
NEW YORK STEM CELL FOUNDATION via MANATT, PHELPS, AND PHILLIPS
2024 · second_quarter · RR
Appropriations and Healthcare
Appropriations and Healthcare